Across TCGA pan-cancer cohorts, MIR938 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR938’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where MIR938 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR938 is over-expressed in tumor, although a few such as UCEC and STAD show the opposite, repressed pattern.

UCEC, STAD, and LUSC are the cancer types where MIR938 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR938 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	−1.395	.001	4	view →
STAD	Female	All	−1.938	.007	2	view →
LUSC	Female	All	−0.371	.018	2	view →
BRCA	All	III,IV	−0.338	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR938 RNA expression & survival · all MIR938 data types